These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7926343)

  • 1. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes.
    Ruiz J; Thillet J; Huby T; James RW; Erlich D; Flandre P; Froguel P; Chapman J; Passa P
    Diabetologia; 1994 Jun; 37(6):585-91. PubMed ID: 7926343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH; Fortmann SP; Marcovina SM
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
    Farrer M; Game FL; Albers CJ; Neil HA; Winocour PH; Laker MF; Adams PC; Alberti KG
    Arterioscler Thromb; 1994 Aug; 14(8):1272-83. PubMed ID: 8049188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
    Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J
    J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
    Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
    Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
    Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
    Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus.
    Labudovic DD; Toseska KN; Alabakovska SB; B Todorova B
    Clin Biochem; 2003 Oct; 36(7):545-51. PubMed ID: 14563448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
    Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
    Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
    Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
    Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
    Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus.
    O'Brien T; Nguyen TT; Harrison JM; Bailey KR; Dyck PJ; Kottke BA
    Mayo Clin Proc; 1994 May; 69(5):430-5. PubMed ID: 8170193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
    J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
    J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
    Mohan V; Deepa R; Haranath SP; Premalatha G; Rema M; Sastry NG; Enas EA
    Diabetes Care; 1998 Nov; 21(11):1819-23. PubMed ID: 9802727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty.
    Sirikci O; Aytekin V; Demiroglu IC; Demiroglu C; Marcovina SM
    Int J Clin Lab Res; 2000; 30(2):93-9. PubMed ID: 11043503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM; Joven J; Vilella E; Ribas M; Pujana MA; Sundaram IM; Hammel JP; Hoover-Plow JL
    Thromb Haemost; 2001 Mar; 85(3):412-7. PubMed ID: 11307806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.
    Emanuele E; Peros E; Minoretti P; Falcone C; D'Angelo A; Montagna L; Geroldi D
    BMC Cardiovasc Disord; 2003 Dec; 3():12. PubMed ID: 14670093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
    Palumbo B; Lupattelli G; Siepi D; Bianchi A; Anniboletti PF; Blandini V; Sinzinger H; Mannarino E; Palumbo R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):987-91. PubMed ID: 12635466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.